Financhill
Sell
30

AJG Quote, Financials, Valuation and Earnings

Last price:
$252.32
Seasonality move :
4.93%
Day range:
$247.10 - $252.11
52-week range:
$236.34 - $351.23
Dividend yield:
1.04%
P/E ratio:
39.84x
P/S ratio:
4.86x
P/B ratio:
2.77x
Volume:
2.7M
Avg. volume:
1.8M
1-year change:
-14.69%
Market cap:
$64.3B
Revenue:
$11.6B
EPS (TTM):
$6.29

Analysts' Opinion

  • Consensus Rating
    Arthur J. Gallagher & Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 8 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $293.56, Arthur J. Gallagher & Co. has an estimated upside of 17.24% from its current price of $250.38.
  • Price Target Downside
    According to analysts, the lowest downside price target is $247.00 representing 100% downside risk from its current price of $250.38.

Fair Value

  • According to the consensus of 19 analysts, Arthur J. Gallagher & Co. has 17.24% upside to fair value with a price target of $293.56 per share.

AJG vs. S&P 500

  • Over the past 5 trading days, Arthur J. Gallagher & Co. has underperformed the S&P 500 by -2.19% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Arthur J. Gallagher & Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Arthur J. Gallagher & Co. has grown year-over-year revenues for 12 quarters straight. In the most recent quarter Arthur J. Gallagher & Co. reported revenues of $3.4B.

Earnings Growth

  • Arthur J. Gallagher & Co. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Arthur J. Gallagher & Co. reported earnings per share of $1.05.
Enterprise value:
76.6B
EV / Invested capital:
--
Price / LTM sales:
4.86x
EV / EBIT:
28.57x
EV / Revenue:
5.88x
PEG ratio (5yr expected):
2.04x
EV / Free cash flow:
43.35x
Price / Operating cash flow:
35.82x
Enterprise value / EBITDA:
20.96x
Gross Profit (TTM):
$11.9B
Return On Assets:
2.27%
Net Income Margin (TTM):
12.33%
Return On Equity:
7.95%
Return On Invested Capital:
4.91%
Operating Margin:
15.94%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $9.6B $11.1B $13B $2.8B $3.4B
Gross Profit $8.9B $10.3B $11.9B $2.6B $3B
Operating Income $1.8B $2.1B $2.7B $480.9M $536.6M
EBITDA $2.5B $3B $3.7B $690.9M $812.9M
Diluted EPS $5.22 $5.26 $6.29 $1.40 $1.05
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $15.1B $23.8B $35.9B $37.3B $43B
Total Assets $26.9B $38.7B $53.2B $57.2B $79.1B
Current Liabilities $11.7B $22.5B $34.5B $35.2B $40.8B
Total Liabilities $18.4B $30B $42.7B $45B $55.8B
Total Equity $8.5B $8.6B $10.5B $12.2B $23.2B
Total Debt $5.6B $6.3B $6.8B $8.3B $13.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $803.1M $2.5B $1.9B $934.8M $731.3M
Cash From Investing -$1.8B -$2.6B -$16.3B -$229.7M -$13.8B
Cash From Financing $2.4B $1.5B $14.4B $610.8M $568.6M
Free Cash Flow $613.1M $2.4B $1.8B $898M $693.5M
AJG
Sector
Market Cap
$64.3B
$548.9M
Price % of 52-Week High
71.29%
92.79%
Dividend Yield
1.04%
1.49%
Shareholder Yield
-12.84%
3.06%
1-Year Price Total Return
-14.69%
9.13%
Beta (5-Year)
0.674
0.451
Dividend yield:
1.04%
Annualized payout:
$2.40
Payout ratio:
62.07%
Growth streak:
14 years

Technicals

8-day SMA
Sell
Level $256.10
200-day SMA
Sell
Level $294.71
Bollinger Bands (100)
Sell
Level 248.54 - 294.68
Chaikin Money Flow
Buy
Level 311.3M
20-day SMA
Sell
Level $259.18
Relative Strength Index (RSI14)
Sell
Level 40.64
ADX Line
Sell
Level 18.43
Williams %R
Neutral
Level -75.3312
50-day SMA
Sell
Level $253.72
MACD (12, 26)
Sell
Level -0.52
25-day Aroon Oscillator
Sell
Level -24
On Balance Volume
Neutral
Level 354.3M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.649)
Sell
CA Score (Annual)
Level (-1.28)
Buy
Beneish M-Score (Annual)
Level (-3.1999)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.5424)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Arthur J. Gallagher & Co. engages in the provision of insurance brokerage, reinsurance brokerage, consulting, and third-party claims settlement and administration services. It operates through the following segments: Brokerage, Risk Management, and Corporate. The Brokerage segment consists of retail and wholesale insurance brokerage operations. The Risk Management segment provides contract claim settlement and administration services. The Corporate segment manages clean energy and other investments. The company was founded by Arthur J. Gallagher in 1927 and is headquartered in Rolling Meadows, IL.

Stock Forecast FAQ

In the current month, AJG has received 8 Buy ratings 11 Hold ratings, and 0 Sell ratings. The AJG average analyst price target in the past 3 months is $293.56.

  • Where Will Arthur J. Gallagher & Co. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Arthur J. Gallagher & Co. share price will rise to $293.56 per share over the next 12 months.

  • What Do Analysts Say About Arthur J. Gallagher & Co.?

    Analysts are divided on their view about Arthur J. Gallagher & Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arthur J. Gallagher & Co. is a Sell and believe this share price will drop from its current level to $247.00.

  • What Is Arthur J. Gallagher & Co.'s Price Target?

    The price target for Arthur J. Gallagher & Co. over the next 1-year time period is forecast to be $293.56 according to 19 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.

  • Is AJG A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Arthur J. Gallagher & Co. is a Hold. 11 of 19 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of AJG?

    You can purchase shares of Arthur J. Gallagher & Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arthur J. Gallagher & Co. shares.

  • What Is The Arthur J. Gallagher & Co. Share Price Today?

    Arthur J. Gallagher & Co. was last trading at $252.32 per share. This represents the most recent stock quote for Arthur J. Gallagher & Co.. Yesterday, Arthur J. Gallagher & Co. closed at $250.38 per share.

  • How To Buy Arthur J. Gallagher & Co. Stock Online?

    In order to purchase Arthur J. Gallagher & Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
69
INTC alert for Jan 23

Intel Corp. [INTC] is down 17.36% over the past day.

Buy
51
APGE alert for Jan 23

Apogee Therapeutics, Inc. [APGE] is down 10.41% over the past day.

Buy
70
BNR alert for Jan 23

Burning Rock Biotech Ltd. [BNR] is down 13.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock